trial · primary record
Etrasimod
Ulcerative Colitis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2033-07-10 |
| Primary endpoint | Proportion of Participants Achieving Clinical Remission as Assessed by Modified Mayo Score (MMS) at Week 52 |
| Registry ID | NCT05287126 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:47.570Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05287126
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.